Zhang Jian
Chairman and Executive Director
The business, the people and the ownership behind AJJ Medtech.
Business overview
AJJ Medtech operates healthcare products, healthcare services and digital healthcare businesses. Its strategic areas include intelligent care robotics, renal care and digital healthcare systems.
Listed security
Board & management
Chairman and Executive Director
Chief Executive Officer and Executive Director
Independent Director
Independent Director
Roles listed in Annual Report 2025; current appointments are not independently verified.
Holdings
Direct interest 361,616,714.00 shares (21.13%); deemed interest 87,428,571.00 shares (5.11%)
As recorded in the Register of Substantial Shareholders; as at 18 March 2026Direct interest 87,428,571.00 shares (5.11%); deemed interest – (–)
As recorded in the Register of Substantial Shareholders; as at 18 March 2026Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 18 March 2026 · PDF p. 123
| Registered holder | Interest | Shares / units | Source |
|---|---|---|---|
| ZHANG JIAN | 361,616,714 shares; 21.13 | PDF p. 12318 March 2026 | |
| DBS NOMINEES PTE LTD | 93,030,354 shares; 5.44 | PDF p. 12318 March 2026 | |
| ZHANG YULEI | 87,428,571 shares; 5.11 | PDF p. 12318 March 2026 | |
| LIU YUNHUA | 70,000,000 shares; 4.09 | PDF p. 12318 March 2026 | |
| HUANG QIANG | 61,408,114 shares; 3.59 | PDF p. 12318 March 2026 | |
| ZHANG YUNHAI | 58,037,143 shares; 3.39 | PDF p. 12318 March 2026 | |
| KOH YEW CHOO | 48,644,000 shares; 2.84 | PDF p. 12318 March 2026 | |
| ZHAO XIN | 39,773,000 shares; 2.32 | PDF p. 12318 March 2026 | |
| MOOMOO FINANCIAL SINGAPORE PTE. LTD. | 35,033,944 shares; 2.05 | PDF p. 12318 March 2026 | |
| ONG BEE HUAT | 30,000,000 shares; 1.75 | PDF p. 12318 March 2026 | |
| PHILLIP SECURITIES PTE LTD | 29,651,629 shares; 1.73 | PDF p. 12318 March 2026 | |
| UOB KAY HIAN PTE LTD | 26,354,700 shares; 1.54 | PDF p. 12318 March 2026 | |
| CHUA JUNE GAY | 23,160,422 shares; 1.35 | PDF p. 12318 March 2026 | |
| BAI HONGFU | 22,637,500 shares; 1.32 | PDF p. 12318 March 2026 | |
| MAYBANK SECURITIES PTE. LTD. | 22,043,753 shares; 1.29 | PDF p. 12318 March 2026 | |
| KOH TIAK CHYE | 18,000,000 shares; 1.05 | PDF p. 12318 March 2026 | |
| UNITED OVERSEAS BANK NOMINEES (PRIVATE) LIMITED | 16,363,000 shares; 0.96 | PDF p. 12318 March 2026 | |
| GOH BEE YONG | 16,000,000 shares; 0.93 | PDF p. 12318 March 2026 | |
| ANG AH LEK @AN AH LEK | 14,000,000 shares; 0.82 | PDF p. 12318 March 2026 | |
| TAN KIM YEOW | 14,000,000 shares; 0.82 | PDF p. 12318 March 2026 | |
Group structure
| Company | Market | Ownership interest |
|---|---|---|
| AJJ Healthcare Management Pte. Ltd.1Held by the Company; effective interests 2025 and 2024 | Singapore; effective equity interest held by the Company: 100% (2025), 100% (2024); Investment holding and management consultancy services for healthcare organisations | |
| W Property Management Pte. Ltd.1, 2Held by the Company; effective interests 2025 and 2024 | Singapore; effective equity interest held by the Company: 100% (2025), 100% (2024); Real estate leasing and management | |
| ESO Health Care Pte. Ltd.1, 2Held by the Company; effective interests 2025 and 2024 | Singapore; effective equity interest held by the Company: 100% (2025), 100% (2024); Investment holding, nurseries and kindergartens | |
| Shanghai Longjian Hospital Management Co., Ltd.2Held by the Company; effective interests 2025 and 2024 | China; effective equity interest held by the Company: 51% (2025), 51% (2024); Hospital management, medical technology, biotechnology, technology development and health management consulting | |
| HIFU Suntec Pte. Ltd.1, 2Held through AJJ Healthcare Management Pte. Ltd.; effective interests 2025 and 2024 | Singapore; effective equity interest held by AJJ Healthcare Management Pte. Ltd.: 80% (2025), 80% (2024); Conduct research and development of medical technologies, manufacture and repair of irradiation and electromedical of HIFU machine and other medical equipment | |
| Quest Asia Technologies Pte. Ltd.1Held through AJJ Healthcare Management Pte. Ltd.; effective interests 2025 and 2024 | Singapore; effective equity interest held by AJJ Healthcare Management Pte. Ltd.: 100% (2025), 100% (2024); Wholesale of medical, professional, scientific and precision equipment | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Ms Zhang Yulei | Chief Strategy Officer | AJJ Medtech Holdings Limited | PDF p. 9 |
| Mr William Ong Hon Hsiang | Executive Director and Chief Executive Officer of AJJ Healthcare Management Pte. Ltd. | AJJ Healthcare Management Pte. Ltd. | PDF p. 9 |
| Mr Chua June Gay Leslie | Director of Corporate Partnerships | AJJ Healthcare Management Pte. Ltd. | PDF p. 9 |
| Dr Tan Weijie | Director of Business Development | AJJ Healthcare Management Pte. Ltd. | PDF p. 9 |
| Mr Tan Kee Hong | Group Financial Controller; Company Secretary | AJJ Medtech Holdings Limited · As at 2025-09-09 | PDF p. 59 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dr Zhang Jian (Lender) interest-free loan | S$500,000 | Company, FY2025 | PDF p. 68 |
| Fees paid to company in which the Company’s key management personnel has a financial interest | 45 S$’000 | Group 2025 (also Group 2024: 45; Company 2025: 45; Company 2024: 45) | PDF p. 115 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Unpaid salaries to employees | S$132,000 | Group, as of 31 December 2025 · As at 2025-12-31 | PDF p. 115 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Dr Zhang Jian | 625,341 S$ | FY2025 total, S$ | PDF p. 58 |
| Ms Zhao Xin | 313,231 S$ | FY2025 total, S$ | PDF p. 58 |
| Mr Chong Eng Wee | 45,600 S$ | FY2025 total, S$ | PDF p. 58 |
| Dr Toh Lim Kai | 43,600 S$ | FY2025 total, S$ | PDF p. 58 |
| Mr Tan Lye Heng Paul | 43,600 S$ | FY2025 total, S$ | PDF p. 58 |
| total remuneration paid to the key management personnel | S$1,001,852 | Five key management personnel (not directors/CEO), FY2025 | PDF p. 59 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Supply contract for biodegradable medical consumables | approximately S$3.0 million | Group, after reporting date | PDF p. 122 |
| Elderly care robotics strategic collaboration | On 2 February 2026, the Company announced certain strategic collaboration and development initiatives relating to elderly care robotics. | Company, after reporting date | PDF p. 122 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Looking Ahead | Future healthcare systems are expected to increasingly rely on intelligent healthcare infrastructure, including robotics, digital healthcare systems and artificial intelligence technologies. | Letter from Chairman & CEO | PDF p. 6 |
Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.
Corporate information